CSTL earnings
Castle Biosciences (CSTL) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
CSTL earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | -0.07 | -0.41 | 82.80% | $103.55M |
| Q1 2026 | May 6, 2026 | -0.49 | -0.49 | 0.00% | $83.68M |
| Q4 2025 | Feb 26, 2026 | -0.08 | -0.23 | 65.22% | $87.01M |
| Q3 2025 | Nov 3, 2025 | -0.02 | -0.34 | 94.12% | $83.04M |
| Q2 2025 | Aug 4, 2025 | 0.15 | -0.51 | 129.41% | $86.19M |
| Q1 2025 | May 5, 2025 | -0.90 | -0.08 | -1025.00% | $87.99M |
| Q4 2024 | Feb 27, 2025 | 0.32 | -0.04 | 900.00% | $86.31M |
| Q3 2024 | Nov 4, 2024 | 0.08 | -0.06 | 233.33% | $85.78M |
| Q2 2024 | Aug 5, 2024 | 0.31 | -0.27 | 214.81% | $87.00M |
| Q1 2024 | May 2, 2024 | -0.09 | -0.37 | 75.68% | $72.97M |
| Q4 2023 | Feb 28, 2024 | -0.10 | -0.84 | 88.10% | $66.12M |
| Q3 2023 | Nov 2, 2023 | -0.26 | -0.92 | 71.74% | $61.49M |
| Aug 2, 2023 | -0.70 | -1.01 | 30.69% | – | |
| May 3, 2023 | -1.10 | -0.80 | -37.50% | – | |
| Feb 28, 2023 | -0.78 | -0.91 | 14.29% | – | |
| Nov 2, 2022 | -0.77 | -0.70 | -10.00% | – | |
| Aug 8, 2022 | -0.06 | -0.58 | 89.66% | – | |
| May 9, 2022 | -0.80 | -0.67 | -19.40% | – | |
| Feb 28, 2022 | -0.25 | -0.43 | 41.86% | – | |
| Nov 8, 2021 | -0.47 | -0.35 | -34.29% | – |
- CSTL reports next on Nov 5, 2026, with EPS of -0.37 expected.
- CSTL beat EPS estimates in 20 of its last 29 reports.
Updated 2026-11-02 17:55 UTC